EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 10 rujna 2024. Database contains 4821 unique substances/entries.
Filter the list
|
208-759-1
|
540-84-1
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
200-906-8
|
75-83-2
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-689-4
|
590-73-8
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-680-5
|
590-35-2
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-207-2
|
560-21-4
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-292-6
|
565-75-3
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
201-193-6
|
79-29-8
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-547-1
|
584-94-1
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-280-0
|
565-59-3
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-649-6
|
589-43-5
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
203-548-0
|
108-08-7
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-745-8
|
592-13-2
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-747-9
|
592-27-8
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-730-6
|
591-76-4
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-243-9
|
563-16-6
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-230-8
|
562-49-2
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-504-7
|
583-48-2
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
210-187-2
|
609-26-7
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
213-923-0
|
1067-08-9
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
210-621-0
|
619-99-8
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
210-529-0
|
617-78-7
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-660-6
|
589-81-1
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-643-3
|
589-34-4
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
202-481-4
|
96-14-0
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-650-1
|
589-53-7
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
203-806-2
|
110-82-7
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
205-563-8
|
142-82-5
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
203-523-4
|
107-83-5
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
-
|
-
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
250-610-8
|
31394-54-4
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
247-861-0
|
26635-64-3
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
203-624-3
|
108-87-2
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
203-892-1
|
111-65-9
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
208-832-8
|
542-88-1
|
Flam. Liq. 2; Carc. 1A; Acute Tox. 2; Acute Tox. 3; Acute Tox. 4 |
|||
|
203-480-1
|
107-30-2
|
Flam. Liq. 2; Carc. 1A; Acute Tox. 4 |
|||
|
200-753-7
|
71-43-2
|
Flam. Liq. 2; Carc. 1A; Muta. 1B; STOT RE 1; Asp. Tox. 1; Eye Irrit. 2; Skin Irrit. 2 |
|||
|
200-878-7
|
75-55-8
|
Flam. Liq. 2; Carc. 1B; Acute Tox. 2; Acute Tox. 1; Eye Dam. 1 |
|||
|
203-466-5
|
107-13-1
|
Flam. Liq. 2; Carc. 1B; Acute Tox. 3; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 |
|||
|
200-316-0
|
57-14-7
|
Flam. Liq. 2; Carc. 1B; Acute Tox. 3; Skin Corr. 1B |
|||
|
201-152-2
|
78-87-5
|
Flam. Liq. 2; Carc. 1B; Acute Tox. 4 |
|||
|
203-458-1
|
107-06-2
|
Flam. Liq. 2; Carc. 1B; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
yes |
||
|
204-818-0
|
126-99-8
|
Flam. Liq. 2; Carc. 1B; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||
|
204-661-8
|
123-91-1
|
Flam. Liq. 2; Carc. 1B; Eye Irrit. 2; STOT SE 3 |
yes |
||
|
205-793-9
|
151-56-4
|
Flam. Liq. 2; Carc. 1B; Muta. 1B; Acute Tox. 2; Acute Tox. 1; Skin Corr. 1B |
|||
|
208-819-7
|
542-56-3
|
Flam. Liq. 2; Carc. 1B; Muta. 2; Acute Tox. 4 |
|||
|
200-825-8
|
74-96-4
|
Flam. Liq. 2; Carc. 2; Acute Tox. 4 |
|||
|
203-550-1
|
108-10-1
|
Flam. Liq. 2; Carc. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3 |
|||
|
203-545-4
|
108-05-4
|
Flam. Liq. 2; Carc. 2; Acute Tox. 4; STOT SE 3 |
|||
|
203-438-2
|
106-88-7
|
Flam. Liq. 2; Carc. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2 |
|||
|
203-726-8
|
109-99-9
|
Flam. Liq. 2; Carc. 2; Eye Irrit. 2; STOT SE 3 |
|||